Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1.
Moreno
Santiago
S
Casado
José L
JL
Pérez-Elías
María J
MJ
Dronda
Fernando
F
Antela
Antonio
A
Moreno
Ana
A
Gutiérrez
Carolina
C
D000480:Alkynes; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines; D003521:Cyclopropanes; D020008:Delavirdine / Q000627:therapeutic use; D024921:Drug Resistance, Multiple, Viral; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D019829:Nevirapine / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; D020008:Delavirdine; C098320:efavirenz